Page 25 - Pharma

Aspen buys AstraZeneca's anaesthetics in a $ 770-mn deal

As per the deal, Aspen will make an upfront payment of $520 mn and additional product sales-related payment of $250 mn to acquire rights to AstraZeneca's global anaesthetics portfolio

Merck to expand e-health solution for MS patients with HAPPYneuron tie up

HAPPYneuron will be available for inclusion in Merck's MSdialog platform for use with Rebif (interferon beta-1a), a drug used to treat relapsing forms of multiple sclerosis (MS)

Gelatine capsules technically better than HPMC, says PHD Chamber to DCGI

The current annual installed capacity of HPMC is around 2 billion compared to gelatine's 120 billion, hence replacing HPMC with gelatine is not a feasible option

Chaturbhuj Pharmaceutical to commercialise ayurvedic diabetes drug

The company has signed licensing agreement with National Research Development Corporation (NRDC) for Ayush-82, developed by Central Council for Research in Ayurvedic Sciences

Jain University ropes in NRDC for technology commercialisation

NRDC will also provide its services in IP evaluation and valuation in terms of their commercial potential to Centre for Nano and Material Sciences, (CNMS) of the university

Teva, Allergan agree to sell 8 products to Dr Reddy's for $350 mn

The acquired portfolio consists of products that are being divested by Teva as a precondition to its closing of the acquisition of Allergan's generics business

Lonza inks commercial manufacturing pact for Bluebird Bio's drugs

The agreement provides for the commercial production of Bluebird Bio's Lenti-D and LentiGlobin drug products at Lonza's dedicated production suites

Engage your employees to enable your growth

Ensuring loyalty is about thinking beyond remuneration and figuring out how to get employees to genuinely engage in the business, says Chaitrali Singh

Wipro ropes in US-based Authentise to offer additive manufacturing services

The partnership will benefit customers from industries such as auto, aerospace, healthcare, consumer electronics, etc who are looking to adopt additive manufacturing (3D printing) technology

Sun Pharma's OTC business forays into dermatology

The business, which current markets dietary supplements, analgesics and antacids, has rolled out Suncros, a sunscreen product

Granules India bags exclusive rights for USpharma Windlas' four products

The Hyderabad-based company will have exclusive marketing rights to the US firm's fingolimod, prasugrel, dronedarone and lurasidone drugs

Medicom takeover to bolster Phillips-Medisize's drug delivery solutions

The addition of Medicom's capabilities expands Phillips-Medisize's end-to-end injectable and inhalation device innovation service solutions for biopharma customer

Zydus Cadila to start phase 2 trials of saroglitazar for liver disease

The company has received US FDA approval to initiate phase 2 clinical trials of saroglitazar in patients with non-alcoholic steatohepatitis (NASH), a liver disease, in the US

Should government be provider or facilitator of healthcare?

While debate continues, Dr Dharminder Nagar feels that the government should play the role of a catalyst or a facilitator to enable a large section of population get access to quality healthcare

Eisai and Novartis to co-promote anticancer drugs in US

Two companies will promote Eisai's anticancer agent Lenvima in combination with everolimus as treatment for advanced renal cell carcinoma in the US

Global cancer treatment market to reach $ 150 bn by 2020: Study

The US now accounts for about 45% of the global oncology market, up from 39% in 2011, due to to the strengthening of the US dollar and rapid adoption of newer therapies, says a new IMS Health study

Strides Shasun receives US FDA's EIR report for Bangalore facility

The company's Bangalore facility manufactures oral dosage forms including tablets, capsules (both hard gelatine and soft gelatine)

Indian telemedicine market to become more than double by 2020

The market is expected to growth from $ 15 million currently to $ 32 million by 2020, says an Assocham study

Lupin receives US FDA's nod for antifungal drug voriconazole

The company has received approval for voriconazole tablet (50 mg & 200 mg) and oral suspension (40 mg/mL) - generic versions of PF Prism CV's Vfend tablet and oral suspension

Stempeutics gets DCGI nod to use stem cell therapy to fight Buerger's Disease

The company, a joint venture between Manipal Education and Cipla, has received approval to market Stempeucel product for treating Critical Limb Ischemia due to Buerger's Disease